Published by
@ShahidNShah
@ShahidNShah
AI drug reaches trials in world first.
For the first time, an AI-made drug has reached the clinical trials stage.
Called DSP-1181, the pharmaceutical drug created by AI technology to treat obsessive-compulsive disorder, is in phase 1 trials in Japan.
Continue reading at healthmanagement.org
Make faster decisions with community advice
- When the health IT expert becomes the patient
- How Chief Medical Officers Plan, Implement and Champion New Technology
- Trump Administration Proposed Budget Envisions Major Medicaid and Other Cuts
- Chinese government releases public app to gauge potential coronavirus exposures
- Medical device manufacturers face challenges preparing for ‘stringent’ new EU Regulation
Next Article
-
When the health IT expert becomes the patient
When healthcare IT professional Laura Jantos became the patient, she gained a new perspective on what is lacking in consumer-facing technologies. Laura Jantos, who is retired as a partner in a …
Posted Feb 13, 2020healthcare it
